BioCentury
ARTICLE | Company News

Third Wave deal with SmithKline

June 22, 2000 7:00 AM UTC

Third Wave Technologies (Madison, Wis.) will use its Invader DNA-based technology platform to generate genotyping and gene expression assays for use by SmithKline (LSE:SB; SBH) in developing therapeut...